Cartesian Therapeutics (RNAC) EPS (Basic) (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly EPS (Basic) of -$0.99 for Q1 2026, down 27.27% year-over-year from -$1.36 in Q1 2025, and up 67.18% quarter-over-quarter from -$3.02 in Q4 2025.
Cartesian Therapeutics (RNAC) EPS (Basic) (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported EPS (Basic) for 12 consecutive years, with -$0.99 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 27.27% year-over-year to -$0.99; the TTM figure through Mar 2026 stood at -$4.34 (down 70.09% YoY), while the FY2025 annual figure was -$5.02, down 11.92% from the prior year.
- EPS (Basic) advanced to -$0.99 in Q1 2026 per RNAC's latest filing, from -$3.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.7 in Q2 2022 and bottomed at -$38.04 in Q4 2023.
- Historically, EPS (Basic) has averaged -$3.12 across 5 years, with a median of -$1.41 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) surged 4056.14% — and 2023, when it tumbled 3214.45%.
- Cartesian Therapeutics' EPS (Basic) stood at $1.22 in 2022, then sank by 3214.45% to -$38.04 in 2023, then jumped by 96.15% to -$1.46 in 2024, then slumped by 106.5% to -$3.02 in 2025, then jumped by 67.18% to -$0.99 in 2026.
- Business Quant data shows RNAC's EPS (Basic) at -$0.99 in Q1 2026, -$3.02 in Q4 2025, and -$0.95 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | 0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.47 |
| Mar 31, 2026 | -0.99 |
| Dec 31, 2025 | -3.02 |
| Sep 30, 2025 | -0.95 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | -0.78 |
| Dec 31, 2024 | -1.46 |
| Sep 30, 2024 | -1.41 |
| Jun 30, 2024 | 0.58 |
| Mar 31, 2024 | -4.59 |
| Dec 31, 2023 | -38.04 |
| Sep 30, 2023 | -1.74 |
| Jun 30, 2023 | -2.23 |
| Mar 31, 2023 | -3.75 |
| Dec 31, 2022 | 1.22 |
| Sep 30, 2022 | -1.55 |
| Jun 30, 2022 | 2.70 |
| Mar 31, 2022 | 2.43 |
| Dec 31, 2021 | 3.21 |
| Sep 30, 2021 | -4.66 |